DCM
FBIO icon

Driehaus Capital Management’s Fortress Biotech FBIO Stock Holding History

Driehaus Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-28,962
Closed -$3.74M – 463
2013
Q2 		$3.74M Buy
+28,962
New +$4.27M 0.16% 185

Other funds holding FBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Driehaus Capital Management's FBIO Position: Q3 2013 in Review

Driehaus Capital Management sold out of Fortress Biotech (FBIO) in Q3 2013, closing a stake of 28,962 shares — an estimated $3.74M sold.

Driehaus Capital Management first reported a position in FBIO in Q2 2013 and held it in 1 quarter. The position peaked at $3.74M in Q2 2013. 81 funds tracked by Wall St. Rank hold FBIO as of Q3 2013.

  • Driehaus Capital Management reported no remaining Fortress Biotech position as of Q3 2013 after selling out during the quarter.
  • Driehaus Capital Management sold 28,962 Fortress Biotech shares in Q3 2013, an estimated $3.74M.
  • Driehaus Capital Management first reported a position in Fortress Biotech in Q2 2013 and held it in 1 quarter.
  • Driehaus Capital Management's Fortress Biotech position peaked at $3.74M in Q2 2013.
  • 81 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2013.

Based on Driehaus Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.